FindTrial
Sign In

Clinical trial to know the efficacy of dexmedetomidine and buprenorphine as an adjuvant to ropivacaine in Ultrasound guided supraclavicular brachial plexus block in upper limb surgeries

A randomised clinical trial to study the efficacy of dexmedetomidine and buprenorphine as an adjuvant to ropivacaine in ultrasound guided supraclavicular brachial plexus block for upper limb surgeries - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106632
Enrollment
120
Registered
2026-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M959- Acquired deformity of musculoskeletal system, unspecified Health Condition 2: M849- Disorder of continuity of bone, unspecified

Interventions

Intervention1: Dexmedetomidine: 25 ml of 0.5% Ropivacaine with dexmedetomidine 1 microgram/kg is used for supraclavicular brachial plexus block in upper limb surgeries, onset of action and duration is

Sponsors

B.L.D.E. (DEEMED TO BE UNIVERSITY) SHRI B. M. PATIL MEDICAL COLLEGE AND RESEARCH CENTRE, VIJAYAPUR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients admitted for upper limb surgeries under Supraclavicular brachial plexus block with ASA Grade I and II

Exclusion criteria

Exclusion criteria: Infection at the site of injection in supraclavicular fossa, Known allergy/hypersensitivity to Local Anaesthetic drug, Presence of coagulopathies , A history of cardiac, respiratory, hepatic, or renal failure, and those who refused local anaesthesia.

Design outcomes

Primary

MeasureTime frame
Assessment of onset and duration of sensory and motor block.Timepoint: Assessment of time taken for motor and sensory action and duration till its action wears off—

Secondary

MeasureTime frame
To monitor intraoperative hemodynamic stability.Timepoint: To study the time taken for the first rescue analgesia and requirement of total dose of rescue analgesia. Assessment of postoperative visual analogue scores (VAS) for both groups at 30mins,1, 2, 6, 8, 10 and 12 hours after surgery and patient satisfaction score at 24hrs.—

Countries

India

Contacts

Public ContactDR VIJAY V KATTI

B.L.D.E. (DEEMED TO BE UNIVERSITY) SHRI B. M. PATIL MEDICAL COLLEGE AND RESEARCH CENTRE, VIJAYAPUR

drvijaykatti@gmail.com9844585900

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026